实验性 Moderna mRNA 疫苗在对抗人类巨细胞病毒方面显示出希望。 An experimental Moderna mRNA vaccine shows promise in combating human cytomegalovirus.

Moderna 的实验性 mRNA 疫苗在对抗人类巨细胞病毒 (CMV) 方面显示出了希望，这是一种常见病毒，在子宫内感染时会伤害新生儿。 Moderna's experimental mRNA vaccine has shown promise in combating human cytomegalovirus (CMV), a common virus that can harm newborns when infected in-utero. 与赛诺菲和诺华之前的 CMV 疫苗相比，该候选疫苗表现出更好的免疫反应。 The vaccine candidate demonstrated better immune responses compared to a previous CMV vaccine from Sanofi and Novartis. Moderna 的疫苗已进入 3 期临床研究，以确定这些卓越的免疫反应是否转化为针对 CMV 的更强保护。 Moderna's vaccine has advanced to a phase 3 clinical study to determine if these superior immune responses translate into stronger protection against CMV.